Developing cooperation between EIPICO and Batterjee Pharma
21 September 2025
Dr. Ahmed Kelani, Chairman of the Board of Directors and Managing Director of EIPICO Pharmaceuticals.
Batterjee Pharma is a role model for Arab cooperation in the field of pharmaceutical manufacturing. We are working with our partners in the KSA, led by Sheikh Mazen Batterjee, Chairman of the Board of Directors of the company, and Dr. Mohamed Mazen Batterjee, General Manager of the company, to develop cooperation between EIPICO and Batterjee Pharma in various fields. This is to affirm & rooten and our strategic partnership that's lasting over twenty years between the two companies, and we are very proud of. Since assuming responsibility, we have been focusing on consolidating and developing this partnership for the benefit of the two great brotherly countries, Egypt and Saudi Arabia.
It is worth noting that Batterjee Pharma was established in March 2006 and began production in 2009.
EIPICO is one of its founding shareholders, with a 30% stake. Dr. Ahmed Kelani is also the First Vice President of Batterjee Pharma, representing EIPICO.